Evidence map›Paper›PMID 39251675›Full record

ArticleScientific reports2024

Size-dependent ability of AtaA to immobilize cells in Acinetobacter sp. Tol 5.

Shogo Yoshimoto, Sota Aoki, Masahito Ishikawa, Atsuo Suzuki, Katsutoshi Hori

Abstract read
In one paragraph

Article in Scientific reports, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Shogo YoshimotoDepartment of Biomolecular Engineering, Graduate School of Engineering, Nagoya University, Nagoya, Aichi, 464-8603, Japan.
Sota AokiDepartment of Biomolecular Engineering, Graduate School of Engineering, Nagoya University, Nagoya, Aichi, 464-8603, Japan.
Masahito IshikawaDepartment of Frontier Bioscience, Faculty of Bioscience, Nagahama Institute of Bio-Science and Technology, Nagahama, Shiga, 526-0829, Japan.
Atsuo SuzukiDepartment of Biomolecular Engineering, Graduate School of Engineering, Nagoya University, Nagoya, Aichi, 464-8603, Japan.
Katsutoshi HoriDepartment of Biomolecular Engineering, Graduate School of Engineering, Nagoya University, Nagoya, Aichi, 464-8603, Japan. khori@chembio.nagoya-u.ac.jp.ORCID 0000-0003-1994-3124

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Microbial cells serve as efficient and environmentally friendly biocatalysts, but their stability and reusability in practical applications must often be improved through immobilization. Acinetobacter sp. Tol 5 shows high adhesiveness to materials due to its large cell surface protein AtaA, which consists of 3630 amino acids (aa). Previously, we developed a method for immobilizing bacteria using AtaA. Herein, we investigated the cell immobilization ability of in-frame deletion (IFD) mutants of AtaA with different sizes in Tol 5. Mini-AtaA, which consists of 775 aa and is functional in Escherichia coli, was produced and present on the cell surface; however, mini-AtaA showed no immobilization ability in Tol 5. A cell immobilization assay was performed with cells expressing 16 IFD mutants of AtaA with different sizes, revealing that a length of at least 1417 aa was required for the sufficient immobilization of Tol 5 cells; thus, the minimum length needed to achieve the adhesive function of AtaA varies among bacterial species. The constructed mutant library of AtaA ranging from 3630 to 775 aa will allow researchers to quickly and easily explore the optimal size of AtaA, even for bacteria newly introduced to AtaA.

Indexed as

AcinetobacterBacterial ProteinsBacterial AdhesionCells, ImmobilizedEscherichia coliMembrane ProteinsBacterial ProteinsMembrane ProteinsAdhesionAutotransporterBacteriaCell surfaceImmobilization

Identifiers

PMID39251675
PMCPMC11385948

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.